Her scientific interests lie mostly in Internal medicine, Kidney disease, Renal function, Risk factor and Creatinine. Linda F. Fried interconnects Endocrinology and Surgery in the investigation of issues within Internal medicine. Her studies deal with areas such as Odds ratio, Nephrology, Nephropathy and Prospective cohort study as well as Kidney disease.
Her work in Renal function addresses subjects such as Hazard ratio, which are connected to disciplines such as Cohort. Her Risk factor research includes elements of Diabetes mellitus, Mortality rate, Proportional hazards model and Cohort study. Her studies examine the connections between Creatinine and genetics, as well as such issues in Heart failure, with regards to Cystatin.
Linda F. Fried mainly investigates Internal medicine, Renal function, Kidney disease, Endocrinology and Creatinine. Her Internal medicine research is multidisciplinary, relying on both Diabetes mellitus and Cardiology. The study incorporates disciplines such as Nephrology, Urology, Heart failure and Confidence interval in addition to Renal function.
Her research integrates issues of Odds ratio, Prospective cohort study, Surgery, Gastroenterology and Disease in her study of Kidney disease. Her Prospective cohort study research incorporates themes from Physical therapy and Gerontology. Her biological study spans a wide range of topics, including Cohort study and C-reactive protein.
Linda F. Fried focuses on Internal medicine, Renal function, Kidney disease, Creatinine and Urology. Her work on Bicarbonate as part of general Internal medicine study is frequently linked to Fibroblast growth factor 23, bridging the gap between disciplines. Her Renal function study deals with Confidence interval intersecting with Oxygenation and Magnetic resonance imaging.
Her Kidney disease research includes themes of Intensive care medicine, Risk factor and Population study. Her Creatinine study combines topics in areas such as Urine, Tamm–Horsfall protein, Kidney and Heart failure. Her work carried out in the field of Urology brings together such families of science as Gold standard, Urine flow rate, Nephrology and Urine collection device.
Her primary areas of investigation include Internal medicine, Renal function, Kidney disease, Diabetes mellitus and Gastroenterology. The concepts of her Renal function study are interwoven with issues in Urology, Urine, Albumin, Creatinine and Type 2 diabetes. Linda F. Fried has researched Creatinine in several fields, including Lower risk, Quartile, Tamm–Horsfall protein, Serum albumin and Risk factor.
Linda F. Fried frequently studies issues relating to Odds ratio and Kidney disease. Her studies in Diabetes mellitus integrate themes in fields like Area under the curve, Prospective cohort study, Surgery, Predictive value of tests and Case-control study. Her study on Gastroenterology is mostly dedicated to connecting different topics, such as Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cystatin C and the risk of death and cardiovascular events among elderly persons.
Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried.
The New England Journal of Medicine (2005)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried;Nicholas Emanuele;Nicholas Emanuele;Jane H. Zhang;Mary Brophy.
The New England Journal of Medicine (2013)
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Linda F. Fried;Linda F. Fried;Trevor J. Orchard;Trevor J. Orchard;Bertram L. Kasiske;Bertram L. Kasiske.
Kidney International (2001)
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Michael G. Shlipak;Linda F. Fried;Casey Crump;Anthony J. Bleyer.
Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors
Michael G. Shlipak;Linda F. Fried;Mary Cushman;Teri A. Manolio.
Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease
Michael G. Shlipak;Ronit Katz;Mark J. Sarnak;Linda F. Fried.
Annals of Internal Medicine (2006)
Statins for Improving Renal Outcomes: A Meta-Analysis
Sabrina Sandhu;Natasha Wiebe;Linda F. Fried;Marcello Tonelli.
Journal of The American Society of Nephrology (2006)
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.
Linda F. Fried;Michael G. Shlipak;Michael G. Shlipak;Casey Crump;Richard A. Kronmal.
Journal of the American College of Cardiology (2003)
Prevalence, Severity, and Importance of Physical and Emotional Symptoms in Chronic Hemodialysis Patients
Steven D. Weisbord;Linda F. Fried;Robert M. Arnold;Michael J. Fine.
Journal of The American Society of Nephrology (2005)
Chronic Kidney Disease and Cognitive Impairment in the Elderly: The Health, Aging, and Body Composition Study
Manjula Kurella;Glenn M. Chertow;Linda F. Fried;Steven R. Cummings;Steven R. Cummings.
Journal of The American Society of Nephrology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: